Drug intelligence / Profile preview

DINA-003

Development stage
Preclinical
Lead developer
DiNAQOR
Modality
Gene Addition/Replacement → Gene Therapies, Gene Editing → Gene Therapies, Gene Silencing → Gene Therapies
Administration
Intracoronary
01

Overview

DINA-003 is an investigational gene therapy candidate being developed by DiNAQOR for the treatment of hypertrophic cardiomyopathy (HCM). HCM is a genetic heart condition characterized by abnormal thickening of the heart muscle, which can lead to heart failure and sudden cardiac death. DINA-003 is currently in the discovery phase and is designed to utilize DiNAQOR's proprietary cardiac-targeted gene therapy platform, which typically employs engineered adeno-associated virus (AAV) vectors to deliver therapeutic transgenes directly to the myocardium. While DiNAQOR's lead program, DINA-001, targets mutations in the *MYBPC3* gene, DINA-003 represents a separate program aimed at addressing HCM through an undisclosed genetic target or therapeutic mechanism.

Other names
DINA 003DINA003DINA-003
02

Targets

MYBPC3 (Myosin-binding protein C, cardiac-type)

Beyond the preview

Go deeper on DINA-003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DINA-003.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call